Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wessels MR et al. | Case records of the Massachusetts General Hospital. Case 6-2015. A 16-year-old boy with coughing spells. | 2015 | N. Engl. J. Med. | pmid:25693017 |
| Knirsch CA and Chandra R | Azithromycin and the risk of cardiovascular death. | 2012 | N. Engl. J. Med. | pmid:22913693 |
| Albert RK et al. | Azithromycin and the risk of cardiovascular death. | 2012 | N. Engl. J. Med. | pmid:22913694 |
| Louie R | Azithromycin and the risk of cardiovascular death. | 2012 | N. Engl. J. Med. | pmid:22913695 |
| Zaidi N and Nawab Q | Antibiotic prevention of acute exacerbations of COPD. | 2012 | N. Engl. J. Med. | pmid:23134397 |
| Koga T and Imaoka H | Azithromycin and the risk of cardiovascular death. | 2012 | N. Engl. J. Med. | pmid:22913696 |
| Siegel D | Antibiotic prevention of acute exacerbations of COPD. | 2012 | N. Engl. J. Med. | pmid:23134398 |
| Pires dos Santos R and Kuchenbecker R | Azithromycin and the risk of cardiovascular death. | 2012 | N. Engl. J. Med. | pmid:22913697 |
| Schwarz DG | Antibiotic prevention of acute exacerbations of COPD. | 2012 | N. Engl. J. Med. | pmid:23134399 |
| Cao B et al. | Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. | 2009 | N. Engl. J. Med. | pmid:20007555 |
| Garcia-Vidal C et al. | Antibiotic prevention of acute exacerbations of COPD. | 2012 | N. Engl. J. Med. | pmid:23134400 |
| Chapman SJ | Antibiotic prevention of acute exacerbations of COPD. | 2012 | N. Engl. J. Med. | pmid:23134401 |
| Wiesenfeld HC | Screening for Chlamydia trachomatis Infections in Women. | 2017 | N. Engl. J. Med. | pmid:28225683 |
| Crooks MG et al. | Azithromycin for prevention of exacerbations of COPD. | 2011 | N. Engl. J. Med. | pmid:22150046 |
| DiNicolantonio JJ | Azithromycin for prevention of exacerbations of COPD. | 2011 | N. Engl. J. Med. | pmid:22150047 |
| West S | The red eye. | 2000 | N. Engl. J. Med. | pmid:11184764 |
| Hahn DL | Azithromycin for prevention of exacerbations of COPD. | 2011 | N. Engl. J. Med. | pmid:22150048 |
| Ragusa A and Svelato A | Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. | 2017 | N. Engl. J. Med. | pmid:28079335 |
| Greig JR and Jones L | Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. | 2017 | N. Engl. J. Med. | pmid:28079334 |
| Martin DH et al. | A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. | 1992 | N. Engl. J. Med. | pmid:1325036 |
| Solomon AW et al. | Mass treatment with single-dose azithromycin for trachoma. | 2004 | N. Engl. J. Med. | pmid:15525721 |
| Lukehart SA et al. | Macrolide resistance in Treponema pallidum in the United States and Ireland. | 2004 | N. Engl. J. Med. | pmid:15247355 |
| Mitchell WM and Stratton CW | Chlamydia pneumoniae and acute coronary syndrome. | 2005 | N. Engl. J. Med. | pmid:16080250 |
| Walterspiel JN | Treatment of cat scratch disease. | 1999 | N. Engl. J. Med. | pmid:10366328 |
| Amory JK et al. | Clinical problem-solving. A jaundiced eye. | 2006 | N. Engl. J. Med. | pmid:16598049 |
| Tepper M et al. | Mass Treatment with Single-Dose Azithromycin for Yaws. | 2016 | N. Engl. J. Med. | pmid:27626527 |
| Eckhoff G et al. | Mass Treatment with Single-Dose Azithromycin for Yaws. | 2016 | N. Engl. J. Med. | pmid:27626526 |
| El-Sadr WM et al. | Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. | 2000 | N. Engl. J. Med. | pmid:10766581 |
| Klass P | Index case. | 2004 | N. Engl. J. Med. | pmid:15141038 |
| Svanström H et al. | Cardiovascular risks with azithromycin. | 2013 | N. Engl. J. Med. | pmid:23924016 |
| McMurray JJ and Jhund PS | Cardiovascular risks with azithromycin. | 2013 | N. Engl. J. Med. | pmid:23924017 |
| Brass EP | Cardiovascular risks with azithromycin. | 2013 | N. Engl. J. Med. | pmid:23924018 |
| Tita AT et al. | Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. | 2016 | N. Engl. J. Med. | pmid:27682034 |
| Mosholder AD and Nambiar S | Cardiovascular risks with azithromycin. | 2013 | N. Engl. J. Med. | pmid:23930274 |
| Havlir DV et al. | Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. | 1996 | N. Engl. J. Med. | pmid:8676932 |
| Riedner G et al. | Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. | 2005 | N. Engl. J. Med. | pmid:16177249 |
| Holmes KK | Azithromycin versus penicillin G benzathine for early syphilis. | 2005 | N. Engl. J. Med. | pmid:16177256 |
| Krause PJ et al. | Atovaquone and azithromycin for the treatment of babesiosis. | 2000 | N. Engl. J. Med. | pmid:11078770 |
| Golden MR et al. | Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. | 2005 | N. Engl. J. Med. | pmid:15716561 |
| Fifer H et al. | Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. | 2016 | N. Engl. J. Med. | pmid:27332921 |
| Kreuter A and Wieland U | Azithromycin versus Doxycycline for Chlamydia. | 2016 | N. Engl. J. Med. | pmid:27144858 |
| Schachter J | Azithromycin versus Doxycycline for Chlamydia. | 2016 | N. Engl. J. Med. | pmid:27144857 |
| Wahlstrom E et al. | Improvement in cyclosporine-associated gingival hyperplasia with azithromycin therapy. | 1995 | N. Engl. J. Med. | pmid:7854392 |
| Wenzel RP et al. | Antibiotic prevention of acute exacerbations of COPD. | 2012 | N. Engl. J. Med. | pmid:22830464 |
| Grayston JT et al. | Azithromycin for the secondary prevention of coronary events. | 2005 | N. Engl. J. Med. | pmid:15843666 |
| Anderson JL | Infection, antibiotics, and atherothrombosis--end of the road or new beginnings? | 2005 | N. Engl. J. Med. | pmid:15843674 |
| Cook JA | Eliminating blinding trachoma. | 2008 | N. Engl. J. Med. | pmid:18434650 |
| Solomon AW et al. | Two doses of azithromycin to eliminate trachoma in a Tanzanian community. | 2008 | N. Engl. J. Med. | pmid:18434662 |
| Geisler WM et al. | Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. | 2015 | N. Engl. J. Med. | pmid:26699167 |
| Harris JB et al. | Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea. | 2011 | N. Engl. J. Med. | pmid:21696312 |
| Albert RK et al. | Azithromycin for prevention of exacerbations of COPD. | 2011 | N. Engl. J. Med. | pmid:21864166 |
| Siafakas NM | Preventing exacerbations of COPD--advice from Hippocrates. | 2011 | N. Engl. J. Med. | pmid:21864170 |
| Edelstein PH | Legionnaires' disease. | 1998 | N. Engl. J. Med. | pmid:9441231 |
| Godofsky EW | Treatment of presumed cerebral toxoplasmosis with azithromycin. | 1994 | N. Engl. J. Med. | pmid:8302335 |
| Mosholder AD et al. | Cardiovascular risks with azithromycin and other antibacterial drugs. | 2013 | N. Engl. J. Med. | pmid:23635046 |
| Svanström H et al. | Use of azithromycin and death from cardiovascular causes. | 2013 | N. Engl. J. Med. | pmid:23635050 |
| Ray WA et al. | Azithromycin and the risk of cardiovascular death. | 2012 | N. Engl. J. Med. | pmid:22591294 |
| Obaro S | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30284804 |
| Michelow IC and Sánchez PJ | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30284803 |
| Cutler T et al. | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30284802 |
| Keenan JD et al. | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30281987 |
| Ballard RC et al. | Azithromycin versus penicillin for early syphilis. | 2006 | N. Engl. J. Med. | pmid:16407519 |
| Klausner JD et al. | Azithromycin versus penicillin for early syphilis. | 2006 | N. Engl. J. Med. | pmid:16411292 |
| Savaris RF and Abeche AM | Azithromycin versus penicillin for early syphilis. | 2006 | N. Engl. J. Med. | pmid:16411293 |
| Khosropour CM et al. | Lack of association between azithromycin and death from cardiovascular causes. | 2014 | N. Engl. J. Med. | pmid:24827057 |
| Schmidt EF and Bretz WA | Benefits of additional courses of systemic azithromycin in periodontal disease case report. | 2007 Jun-Jul | N Y State Dent J | pmid:17891880 |
| Freeman E et al. | Bug breakfast in the Bulletin: Genital Chlamydia trachomatis infection. | 2010 Nov-Dec | N S W Public Health Bull | pmid:21426854 |
| Islam MN et al. | Efficacy of azithromycin in the treatment of childhood typhoid Fever. | 2007 | Mymensingh Med J | pmid:17703150 |
| Hasibur MR and Meraj Z | Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment. | 2013 | Mymensingh Med J | pmid:23416807 |
| Dimitrijević A et al. | Micronucleus frequency in women with genital Chlamydia Trachomatis infection before and after therapy. | 2006 | Mutat. Res. | pmid:16777475 |
| Amacher DE et al. | Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. | 1993 | Mutat. Res. | pmid:7685497 |
| Popovic M et al. | Antioxidant effects of some drugs on immobilization stress combined with cold restraint stress. | 2009 | Molecules | pmid:19924083 |
| Zuo GY et al. | Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA). | 2012 | Molecules | pmid:22932213 |
| Wang CM et al. | Synthesis and Antibacterial Evaluation of a Series of 11,12-Cyclic Carbonate Azithromycin-3-O-descladinosyl-3-O-carbamoyl Glycosyl Derivatives. | 2017 | Molecules | pmid:29207567 |
| Popovic M et al. | Antioxidant effects of some drugs on ethanol-induced ulcers. | 2009 | Molecules | pmid:19255541 |
| Popovic M et al. | Effects of various drugs on alcohol-induced oxidative stress in the liver. | 2008 | Molecules | pmid:18830154 |
| Varano GP et al. | Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat. | 2017 | Mol. Vis. | pmid:29296071 |
| Fernandez-Robredo P et al. | Azithromycin reduces inflammation in a rat model of acute conjunctivitis. | 2013 | Mol. Vis. | pmid:23378729 |
| Snider LA and Swedo SE | PANDAS: current status and directions for research. | 2004 | Mol. Psychiatry | pmid:15241433 |
| Dinos GP et al. | Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. | 2001 | Mol. Pharmacol. | pmid:11353804 |
| Adrjanowicz K et al. | Molecular dynamics in supercooled liquid and glassy states of antibiotics: azithromycin, clarithromycin and roxithromycin studied by dielectric spectroscopy. Advantages given by the amorphous state. | 2012 | Mol. Pharm. | pmid:22540343 |
| Idkaidek N and Arafat T | Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system. | 2012 | Mol. Pharm. | pmid:22784220 |
| Warner DM et al. | Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. | 2008 | Mol. Microbiol. | pmid:18761689 |
| Chen M et al. | Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells. | 2015 | Mol Med Rep | pmid:25607112 |
| Masters EJ | Early treatment of tick borne illnesses. | 2009 Jul-Aug | Mo Med | pmid:19753912 |
| Rajaii RM et al. | Acute generalized exanthematous pustulosis reported due to loxosceles envenomation may be secondary to azithromycin therapy. | 2014 May-Jun | Mo Med | pmid:25011333 |
| Mueller M | Dr. Mueller and fellow authors reply. | 2014 May-Jun | Mo Med | pmid:25011334 |
| Del Rosario ME et al. | Drug-induced QT prolongation and sudden death. | 2010 Jan-Feb | Mo Med | pmid:20222297 |
| Tiwari T et al. | Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. | 2005 | MMWR Recomm Rep | pmid:16340941 |
| Azithromycin treatment failures in syphilis infections--San Francisco, California, 2002-2003. | 2004 | MMWR Morb. Mortal. Wkly. Rep. | pmid:15017376 | |
| Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009. | 2011 | MMWR Morb. Mortal. Wkly. Rep. | pmid:21566558 | |
| Weston EJ et al. | Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea - STD Surveillance Network, United States, 2016. | 2018 | MMWR Morb. Mortal. Wkly. Rep. | pmid:29698384 |
| Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. | 2000 | MMWR Morb. Mortal. Wkly. Rep. | pmid:11012233 | |
| Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. | 2012 | MMWR Morb. Mortal. Wkly. Rep. | pmid:22874837 | |
| Notes from the field: Outbreak of infections caused by Shigella sonnei with decreased susceptibility to azithromycin--Los Angeles, California, 2012. | 2013 | MMWR Morb. Mortal. Wkly. Rep. | pmid:23466436 | |
| Heiman KE et al. | Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men - United States, 2002-2013. | 2014 | MMWR Morb. Mortal. Wkly. Rep. | pmid:24522098 |
| Bowen A et al. | Notes from the Field: Outbreaks of Shigella sonnei Infection with Decreased Susceptibility to Azithromycin Among Men Who Have Sex with Men - Chicago and Metropolitan Minneapolis-St. Paul, 2014. | 2015 | MMWR Morb. Mortal. Wkly. Rep. | pmid:26042652 |
| Notes from the field: respiratory diphtheria-like illness caused by toxigenic Corynebacterium ulcerans --- Idaho, 2010. | 2011 | MMWR Morb. Mortal. Wkly. Rep. | pmid:21270746 | |
| [Azithromycin for pediatric indications. Brief therapy is ideal for children]. | 2002 | MMW Fortschr Med | pmid:12532527 | |
| [Brief antibiotic therapy. 3 swallows in suppurative bronchitis]. | 2004 | MMW Fortschr Med | pmid:15347057 |